A & B PHARMACY LTDActive

Company number SC636867Private limited companyIncorporated 2019

Key figures

£3,488,989-1.8%
Net assets 2024/25
-1 m01 m2 m3 m4 m2019/202020/212021/222022/232023/242024/25

Like most small UK companies, A & B PHARMACY LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
02.5 m5 m7.5 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Total assets3,661,5904,866,5546,778,0146,225,7796,451,204
Total liabilities1,918,4002,285,964656,697197,235514,445
Net assets / total equity19,19148,4223,619,2173,552,7673,488,989
Average number of employees11110

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

The principal activity of the company continued to be that of a holding company.

As described in the company's latest filed accounts.

Summary: A & B PHARMACY LTD

Company

A & B PHARMACY LTD is a private limited company registered with Companies House under company number SC636867. It was incorporated on 23 Jul 2019. Its status is active. The registered office is in Glasgow (G2). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Oct 2025); the company files micro-entity accounts. Net assets were £3,488,989, down 1.8% on the previous year. Total assets were £6,451,204 and total liabilities £514,445. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered. 2 of 2 registered charges are outstanding.

Filing deadlines

The next accounts are due by 31 Jul 2027. The next confirmation statement is due by 5 Aug 2027.